Keywords: bioglan, sees, net, leap, sales, up, uk-based
Bioglan sees net leap 85%, sales up 66%
Article | 20 April 2001
UK-based specialty pharmaceutical company Bioglan reported turnover ofL100.6 million ($144.8 million) for its fiscal year ended January 31,with product sales rising 43% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
